In 2012, the U.S. Congress directed the GAO to study drug shortages through the Food and Drug Administration Safety and Innovation Act.
The report also recognized the FDA has improved its response to drug shortages and has effectively worked to prevent more potential shortages, however, “challenges remain.”
The ASA is reviewing the report and its recommendations.
More Articles on Anesthesia:
3 ASA Anesthesiologists to Travel to Rwanda for Teaching Program
PhyMed Names Michael Morgan COO of Anesthesia Medical Group
Dr. Brian Jones Joins Providence Pain Management Center
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
